Insiders · QTTB

QTTB insider transactions

Q32 Bio Inc. (QTTB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for QTTB

• 12h
  New insider Atlas Venture Opportunity Fund Ill, L.P. claimed ownership of 625,000 shares (SEC Form 3)

  3 - Q32 Bio Inc. (0001661998) (Issuer)
• 7d
  Director Xu Diyong bought $15,000,000 worth of shares (1,875,000 units at $8.00) (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 7d
  Director Orbimed Advisors Llc bought $15,000,000 worth of shares (1,875,000 units at $8.00) (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 80d
  SEC Form 4 filed by Violette Shelia M.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 80d
  SEC Form 4 filed by Kalowski Lee

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 80d
  SEC Form 4 filed by Morrison Jodie Pope

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 101d
  CEO Morrison Jodie Pope sold $44,675 worth of shares (9,896 units at $4.51), decreasing direct ownership by 10% to 89,104 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 101d
  Chief Scientific Officer Violette Shelia M. sold $12,708 worth of shares (2,815 units at $4.51), decreasing direct ownership by 5% to 55,569 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 101d
  CFO and President Kalowski Lee sold $18,035 worth of shares (3,995 units at $4.51), decreasing direct ownership by 10% to 35,943 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 129d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 129d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 129d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 186d
  CFO and President Kalowski Lee sold $31,395 worth of shares (9,072 units at $3.46), decreasing direct ownership by 19% to 39,938 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 186d
  CEO Morrison Jodie Pope sold $77,871 worth of shares (22,506 units at $3.46), decreasing direct ownership by 19% to 99,000 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Iwicki Mark T

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Xu Diyong

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Thistle Mary

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Tzianabos Arthur

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 224d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 284d
  CEO Morrison Jodie Pope sold $18,900 worth of shares (10,494 units at $1.80), decreasing direct ownership by 8% to 121,506 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 284d
  Chief Scientific Officer Violette Shelia M. sold $5,385 worth of shares (2,990 units at $1.80), decreasing direct ownership by 5% to 58,384 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 284d
  CFO and President Kalowski Lee sold $7,636 worth of shares (4,240 units at $1.80), decreasing direct ownership by 8% to 49,010 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 466d
  SEC Form 4 filed by Director Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 466d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 466d
  CFO and President Kalowski Lee was granted 53,250 shares (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 466d
  SEC Form 4 filed by Director Tzianabos Arthur

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  SEC Form 4 filed by Director Xu Diyong

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  CEO Morrison Jodie Pope was granted 132,000 shares (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  SEC Form 4 filed by Director Iwicki Mark T

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  Chief Medical Officer Campagna Jason was granted 37,500 shares (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  SEC Form 4 filed by Director Thistle Mary

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  Chief Scientific Officer Violette Shelia M. was granted 37,500 shares, increasing direct ownership by 157% to 61,374 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 467d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 600d
  Chief Scientific Officer Violette Shelia M. exercised 10,574 shares at a strike of $5.49, increasing direct ownership by 80% to 23,874 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 606d
  Chief Scientific Officer Violette Shelia M. exercised 13,300 shares at a strike of $3.12 (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 616d
  SEC Form 4 filed by Director Manke Isaac

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 619d
  SEC Form 4 filed by Director Lundberg Sven Ante

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 663d
  SEC Form 4 filed by Director Grayzel David S.

  4 - Q32 Bio Inc. (0001661998) (Issuer)
• 663d
  Director Tzianabos Arthur converted options into 1,095 shares and sold $6,413 worth of shares (265 units at $24.20), increasing direct ownership by 12% to 7,983 units (SEC Form 4)

  4 - Q32 Bio Inc. (0001661998) (Issuer)